Ralph Santos‐Oliveira

ORCID: 0000-0002-7221-6404 · 2 papers in corpus

article 2017

Development and Application of a Nanoradiopharmaceutical Based on the Monoclonal Antibody Bevacizumab for Endometriosis: Comparison Between Normal and Nanoparticulate Monoclonal Antibody as Imaging Radiopharmaceutical

·doi:10.1166/asem.2017.2074

article 2015

Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis

BioMed research international ·doi:10.1155/2015/751460

The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial grow…